Shares of Aurobindo Pharma gained over 2% in intraday trade on Thursday ahead of the company’s Q4 FY26 results announcement, with investors closely tracking the stock ahead of its earnings release later in the day.
As of 1:55 pm, the stock was trading near its intraday high after witnessing steady buying activity through the session. According to market data visible on trading platforms, Aurobindo Pharma touched an intraday high of Rs 1,548.80, which also marked its 52-week high level. The stock’s intraday low stood at Rs 1,515.50.
The stock opened at Rs 1,523 compared to the previous close of Rs 1,517.50. Trading volumes remained active during the session, indicating increased investor participation ahead of the quarterly earnings announcement.
Stocks often witness heightened volatility ahead of earnings announcements as traders position themselves based on expectations around financial performance and future guidance.
The stock reaction comes as investors await the company’s Q4 numbers, with market focus likely to remain on earnings performance and management outlook in the near term.
Disclaimer: This article is generated for informational purposes only and does not constitute financial, investment, or trading advice. The data and analysis presented are based on publicly available market information at the time of writing. Markets are subject to risk. Please consult a qualified financial advisor before making any investment or trading decisions. Business Upturn does not accept responsibility for any losses arising from reliance on this content.